{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:41:31Z","timestamp":1779334891603,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00284-023-03242-y","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:57:57Z","timestamp":1680501477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Repositioning of Benzodiazepine Drugs and Synergistic Effect with Ciprofloxacin Against ESKAPE Pathogens"],"prefix":"10.1007","volume":"80","author":[{"given":"Taci\u00e9li F.","family":"da Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa B.","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vit\u00f3ria S.","family":"Foletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00edsa N.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno R.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana B.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Calegari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosmari","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"issue":"1","key":"3242_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/ijms22010456","volume":"22","author":"S Rentschler","year":"2021","unstructured":"Rentschler S, Kaiser L, Deigner HP (2021) Emerging options for the diagnosis of bacterial infections and the characterization of antimicrobial resistance. Int J Mol Sci 22(1):456. https:\/\/doi.org\/10.3390\/ijms22010456. (PMID: 33466437)","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3242_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4236\/aid.2018.83012","volume":"8","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Singh PK, Vatsalya V et al (2018) Developments in the diagnostic techniques of infectious diseases: rural and urban prospective. Adv Infect Dis 8(3):121\u2013138. https:\/\/doi.org\/10.4236\/aid.2018.83012. (PMID: 30197838)","journal-title":"Adv Infect Dis"},{"key":"3242_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1128\/JCM.02264-16","volume":"3","author":"K Messacar","year":"2017","unstructured":"Messacar K, Parker SK, Todd JK et al (2017) Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol 3:715\u2013723. https:\/\/doi.org\/10.1128\/JCM.02264-16. (PMID: 28031432)","journal-title":"J Clin Microbiol"},{"key":"3242_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5902\/2236583443061","volume":"46","author":"TF da Rosa","year":"2020","unstructured":"da Rosa TF, Foletto VS, Serafin MB et al (2020) Emerging strategies for ESKAPE treatment. Sa\u00fade 46:1. https:\/\/doi.org\/10.5902\/2236583443061","journal-title":"Sa\u00fade"},{"issue":"3","key":"3242_CR5","doi-asserted-by":"publisher","first-page":"106380","DOI":"10.1016\/j.ijantimicag.2021.106380","volume":"58","author":"VS Foletto","year":"2021","unstructured":"Foletto VS, da Rosa TF, Serafin MB et al (2021) Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. Int J Antimicrob Agents 58(3):106380. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106380. (PMID: 34166776)","journal-title":"Int J Antimicrob Agents"},{"key":"3242_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN et al (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 10:539. https:\/\/doi.org\/10.3389\/fmicb.2019.00539. (PMID: 30988669)","journal-title":"Front Microbiol"},{"issue":"8","key":"3242_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice LB (2008) Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197(8):1079\u20131081. https:\/\/doi.org\/10.1086\/533452. (PMID: 18419525)","journal-title":"J Infect Dis"},{"issue":"4","key":"3242_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jcpt.13149","volume":"45","author":"TF da Rosa","year":"2020","unstructured":"da Rosa TF, Coelho SS, Foletto VS et al (2020) Alternatives for the treatment of infections caused by ESKAPE pathogens. J Clin Pharm Ther 45(4):863\u2013873. https:\/\/doi.org\/10.1111\/jcpt.13149. (PMID: 32339305)","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"3242_CR9","doi-asserted-by":"publisher","first-page":"e06310","DOI":"10.1016\/j.heliyon.2021.e06310","volume":"7","author":"P Bhatia","year":"2021","unstructured":"Bhatia P, Sharma A, George AJ et al (2021) Antibacterial activity of medicinal plants against ESKAPE: an update. Heliyon 7(2):e06310. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06310. (PMID: 33718642)","journal-title":"Heliyon"},{"issue":"3","key":"3242_CR10","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Forde BM, Kidd TJ et al (2020) Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33(3):e00181-e219. https:\/\/doi.org\/10.1128\/CMR.00181-19. (PMID: 32404435)","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"3242_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14787210.2021.1858800","volume":"19","author":"A Patil","year":"2021","unstructured":"Patil A, Banerji R, Kanojiya P et al (2021) Bacteriophages for ESKAPE: role in pathogenicity and measures of control. Expert Rev Anti Infect Ther 19(7):845\u2013865. https:\/\/doi.org\/10.1080\/14787210.2021.1858800. (PMID: 33261536)","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"3242_CR12","doi-asserted-by":"publisher","first-page":"ofz503","DOI":"10.1093\/ofid\/ofz503","volume":"2","author":"JE Marturano","year":"2019","unstructured":"Marturano JE, Lowery TJ (2019) ESKAPE pathogens in bloodstream infections are associated with higher cost and mortality but can be predicted using diagnoses upon admission. Open Forum Infect Dis. 2(12):ofz503. https:\/\/doi.org\/10.1093\/ofid\/ofz503. (PMID: 31844639)","journal-title":"Open Forum Infect Dis."},{"issue":"3","key":"3242_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5902\/2236583440016","volume":"45","author":"VS Foletto","year":"2019","unstructured":"Foletto VS, Bottega A, Serafin MB et al (2019) Etiological and antimicrobial susceptibility profile of isolated blood cultures in a university hospital. Sa\u00fade (Santa Maria) 45(3):1\u201315. https:\/\/doi.org\/10.5902\/2236583440016","journal-title":"Sa\u00fade (Santa Maria)"},{"issue":"4","key":"3242_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.idc.2020.08.004","volume":"34","author":"WR Miller","year":"2020","unstructured":"Miller WR, Murray BE, Rice LB et al (2020) Resistance in vancomycin resistant enterococci. Infect Dis Clin North Am 34(4):751\u2013771. https:\/\/doi.org\/10.1016\/j.idc.2020.08.004. (PMID: 33131572)","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"3242_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00284-022-02794-9","volume":"79","author":"MB Serafin","year":"2022","unstructured":"Serafin MB, Foletto VS, da Rosa TF et al (2022) Repositioning of disulfiram in association with vancomycin against Enterococcus spp. MDR and XDR Curr Microbiol 79(5):137. https:\/\/doi.org\/10.1007\/s00284-022-02794-9. (PMID: 35303186)","journal-title":"MDR and XDR Curr Microbiol"},{"issue":"1","key":"3242_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13065-020-00669-3","volume":"14","author":"P Kumar","year":"2020","unstructured":"Kumar P (2020) A review on quinoline derivatives as anti-methicillin resistant Staphylococcus aureus (MRSA) agents. BMC Chem 14(1):17. https:\/\/doi.org\/10.1186\/s13065-020-00669-3. (PMID: 32190843)","journal-title":"BMC Chem"},{"issue":"7","key":"3242_CR17","doi-asserted-by":"publisher","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Hsueh PR, Mendes RE et al (2019) The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 63(7):e00355-e419. https:\/\/doi.org\/10.1128\/AAC.00355-19. (PMID: 31010862)","journal-title":"Antimicrob Agents Chemother"},{"key":"3242_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jgar.2020.07.025","volume":"23","author":"LV Perdig\u00e3o Neto","year":"2020","unstructured":"Perdig\u00e3o Neto LV, Oliveira MS, Orsi TD et al (2020) Alternative drugs against multiresistant gram-negative bacteria. J Glob Antimicrob Resist 23:33\u201337. https:\/\/doi.org\/10.1016\/j.jgar.2020.07.025. (PMID: 32822906)","journal-title":"J Glob Antimicrob Resist"},{"issue":"50","key":"3242_CR19","doi-asserted-by":"publisher","first-page":"e23410","DOI":"10.1097\/MD.0000000000023410","volume":"99","author":"S Jin","year":"2020","unstructured":"Jin S, Lee JY, Park JY et al (2020) Xpert Carba-R assay for detection of carbapenemase-producing organisms in patients admitted to emergency rooms. Medicine (Baltimore) 99(50):e23410. https:\/\/doi.org\/10.1097\/MD.0000000000023410. (PMID: 33327265)","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3242_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhin.2017.08.012","volume":"97","author":"MC Salom\u00e3o","year":"2017","unstructured":"Salom\u00e3o MC, Guimar\u00e3es T, Duailibi DF et al (2017) Carbapenem-resistant enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. J Hosp Infect 97(3):241\u2013246. https:\/\/doi.org\/10.1016\/j.jhin.2017.08.012. (PMID: 28826688)","journal-title":"J Hosp Infect"},{"key":"3242_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673\u2013683. https:\/\/doi.org\/10.1038\/nrd1468. (PMID: 15286734)","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"3242_CR22","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/bib\/bbz176","volume":"22","author":"H Luo","year":"2021","unstructured":"Luo H, Li M, Yang M et al (2021) Biomedical data and computational models for drug repositioning: a comprehensive review. Brief Bioinform 22(2):1604\u20131619. https:\/\/doi.org\/10.1093\/bib\/bbz176. (PMID: 32043521)","journal-title":"Brief Bioinform"},{"issue":"3","key":"3242_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bjid.2018.05.007","volume":"22","author":"MB Serafin","year":"2018","unstructured":"Serafin MB, H\u00f6rner R (2018) Drug repositioning, a new alternative in infectious diseases. Braz J Infect Dis 22(3):252\u2013256. https:\/\/doi.org\/10.1016\/j.bjid.2018.05.007. (PMID: 29963991)","journal-title":"Braz J Infect Dis"},{"issue":"8","key":"3242_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1139\/cjm-2020-0546","volume":"67","author":"TF da Rosa","year":"2021","unstructured":"da Rosa TF, Machado CS, Serafin MB et al (2021) Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA. Can J Microbiol 67(8):599\u2013612. https:\/\/doi.org\/10.1139\/cjm-2020-0546. (PMID: 33481681)","journal-title":"Can J Microbiol"},{"key":"3242_CR25","unstructured":"Mouthon F, Charveriat M. (2014) Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis. WO Patent 2014\u20132803365A1, filled May 14, 2013, issued Nov 19, 2014."},{"issue":"1","key":"3242_CR26","doi-asserted-by":"publisher","first-page":"e3435","DOI":"10.1371\/journal.pntd.0003435","volume":"9","author":"BJ Neves","year":"2015","unstructured":"Neves BJ, Braga RC, Bezerra JC et al (2015) In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni. PLoS Negl Trop Dis. 9(1):e3435. https:\/\/doi.org\/10.1371\/journal.pntd.0003435. (PMID: 25569258)","journal-title":"PLoS Negl Trop Dis."},{"issue":"2","key":"3242_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2217\/fmb-2020-0080","volume":"16","author":"MA Holanda","year":"2021","unstructured":"Holanda MA, da Silva CR, de A Neto JB et al (2021) Evaluation of the antifungal activity in vitro of midazolam against fluconazole-resistant Candida spp. isolates. Future Microbiol. 16(2):71\u201381. https:\/\/doi.org\/10.2217\/fmb-2020-0080. (PMID: 33459560)","journal-title":"Future Microbiol."},{"issue":"8","key":"3242_CR28","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1080\/07391102.2020.1758791","volume":"39","author":"AD Elmezayen","year":"2021","unstructured":"Elmezayen AD, Al-Obaidi A, \u015eahin AT et al (2021) Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn 39(8):2980\u20132992. https:\/\/doi.org\/10.1080\/07391102.2020.1758791. (PMID: 32306862)","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"3242_CR29","doi-asserted-by":"publisher","first-page":"e024648","DOI":"10.1371\/journal.pone.0204648","volume":"13","author":"K Hosomi","year":"2018","unstructured":"Hosomi K, Fujimoto M, Ushio K et al (2018) An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs. PLoS ONE 13(10):e024648. https:\/\/doi.org\/10.1371\/journal.pone.0204648. (PMID: 30300381)","journal-title":"PLoS ONE"},{"issue":"3","key":"3242_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/ijms20030670","volume":"20","author":"T Karakida","year":"2019","unstructured":"Karakida T, Onuma K, Saito MM et al (2019) Potential for drug repositioning of midazolam for dentin regeneration. Int J Mol Sci 20(3):670. https:\/\/doi.org\/10.3390\/ijms20030670. (PMID: 30720745)","journal-title":"Int J Mol Sci"},{"issue":"17","key":"3242_CR31","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/molecules25173959","volume":"25","author":"L Cordeiro","year":"2020","unstructured":"Cordeiro L, Diniz-Neto H, Figueiredo P et al (2020) Potential of 2-Chloro-N-(4-fluoro-3-nitrophenyl)acetamide against Klebsiella pneumoniae and in vitro toxicity analysis. Mol 25(17):3959. https:\/\/doi.org\/10.3390\/molecules25173959. (PMID: 32877986)","journal-title":"Mol"},{"issue":"3","key":"3242_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1590\/S1517-83822010000300014","volume":"41","author":"A Mandal","year":"2010","unstructured":"Mandal A, Sinha C, Kumar JA et al (2010) An investigation on in vitro and in vivo antimicrobial properties of the antidepressant: amitriptyline hydrochloride. Braz J Microbiol 41(3):635\u2013645. https:\/\/doi.org\/10.1590\/S1517-83822010000300014. (PMID: 24031539)","journal-title":"Braz J Microbiol"},{"key":"3242_CR33","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1590\/1413-81232015214.10292015","volume":"21","author":"DCC Naloto","year":"2016","unstructured":"Naloto DCC, Lopes FC, Barberato-Filho S et al (2016) Prescription of benzodiazepines for adults and older adults from a mental health clinic. Cien Saude Colet 21:1267\u20131276. https:\/\/doi.org\/10.1590\/1413-81232015214.10292015","journal-title":"Cien Saude Colet"},{"issue":"8","key":"3242_CR34","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1590\/1413-81232018248.23232017","volume":"24","author":"RT Zorzanelli","year":"2019","unstructured":"Zorzanelli RT, Giordani F, Guaraldo L et al (2019) Comsumption of the benzodiazepine clonazepam (Rivotril\u00ae) in Rio de Janeiro State, Brazil, 2009\u20132013: an ecological study. Ci\u00eanc Sa\u00fade Coletiva 24(8):3129\u20133140. https:\/\/doi.org\/10.1590\/1413-81232018248.23232017","journal-title":"Ci\u00eanc Sa\u00fade Coletiva"},{"key":"3242_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1586\/14737175.2015.1003043","volume":"2","author":"A Verrotti","year":"2015","unstructured":"Verrotti A, Milioni M, Zaccara G (2015) Safety and efficacy of diazepam autoinjector for the management of epilepsy. Expert Rev Neurother 2:127\u2013133. https:\/\/doi.org\/10.1586\/14737175.2015.1003043. (PMID: 25614951)","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"3242_CR36","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00044-013-0694-1","volume":"23","author":"M Babu","year":"2014","unstructured":"Babu M, Pitchumani K, Ramesh P (2014) Synthesis of 5-benzyl-4-aryl-octahydro-1H-benzo[b][1,5]diazepin-2-ones as potent antidepressant and antimicrobial agentes. Med Chem Res 23(4):2070\u20132079. https:\/\/doi.org\/10.1007\/s00044-013-0694-1","journal-title":"Med Chem Res"},{"issue":"19","key":"3242_CR37","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1039\/c5ob00655d","volume":"13","author":"LZ Wang","year":"2015","unstructured":"Wang LZ, Li XQ, An YS (2015) 1,5-Benzodiazepine derivatives as potential antimicrobial agents: design, synthesis, biological evaluation, and structure-activity relationships. Org Biomol Chem 13(19):5497\u20135509. https:\/\/doi.org\/10.1039\/c5ob00655d","journal-title":"Org Biomol Chem"},{"issue":"8","key":"3242_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.2174\/1573406415666190826160251","volume":"16","author":"O Hamed","year":"2020","unstructured":"Hamed O, Fares O, Taleeb S et al (2020) New insights towards 1,4-benzodiazepines from curcumin design. Synth Antimicrob Act Med Chem 16(8):1112\u20131123. https:\/\/doi.org\/10.2174\/1573406415666190826160251","journal-title":"Synth Antimicrob Act Med Chem"},{"issue":"3","key":"3242_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0163-7258(95)02043-8","volume":"69","author":"GAR Johnston","year":"1996","unstructured":"Johnston GAR (1996) GABA a receptor pharmacology. Pharmacol Ther 69(3):173\u2013198","journal-title":"Pharmacol Ther"},{"issue":"5","key":"3242_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2710.1999.00247.x","volume":"24","author":"E Tanaka","year":"1999","unstructured":"Tanaka E (1999) Clinically significant pharmacokinetic drug interactions with benzodiazepines. J Clin Pharm Ther 24(5):347\u2013355. https:\/\/doi.org\/10.1046\/j.1365-2710.1999.00247.x","journal-title":"J Clin Pharm Ther"},{"key":"3242_CR41","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. (2016) 26th ed. CLSI supplement M100S. Wayne, PA: Clinical and Laboratory Standards Institute."},{"key":"3242_CR42","unstructured":"National Committee for Clinical Laboratory Standards\u00a0(NCCLS) (1999) Methods for Determining Bactericidal Activity of antimicrobial agents; Aproved Guideline, NCCLS document M26-A. National Committee for Clinical Laboratory Standards."},{"key":"3242_CR43","unstructured":"Lorian V. (1986) Antibiotics in Laboratory Medicine. 1\u00ba ed. Williams & Wilkins, London. https:\/\/www.dilivros.com.br\/livro-antibiotics-in-laboratory-medicine9781451176759,ams002.html. Access May 20, 2021."},{"key":"3242_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-0711-11-18","volume":"11","author":"K Konat\u00e9","year":"2012","unstructured":"Konat\u00e9 K, Mavoungou JF, Lepengu\u00e9 AN et al (2012) Antibacterial activity against \u03b2- lactamase producing Methicillin and Ampicillin resistants Staphylococcus aureus: fractional inhibitory concentration index (FICI) determination. Ann Clin Microbiol Antimicrob 11:18. https:\/\/doi.org\/10.1186\/1476-0711-11-18. (PMID: 22716026)","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"3242_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52(1):1. https:\/\/doi.org\/10.1093\/jac\/dkg301. (PMID: 12805255)","journal-title":"J Antimicrob Chemother"},{"key":"3242_CR46","unstructured":"ANVISA. (2017). Management of Surveillance and Monitoring in Health Services - GVIMS and General Management of Technology in Health Services - GGTES. National Health Surveillance Agency."},{"key":"3242_CR47","unstructured":"ANVISA. (2021). TECHNICAL NOTE GVIMS\/GGTES\/ANVISA No 06\/2021 Implementation of the Antimicrobial Use Management Program (PGA) by hospitals. National Health Surveillance Agency."},{"key":"3242_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/bph.13895","volume":"2","author":"W Zheng","year":"2018","unstructured":"Zheng W, Sun W, Simeonov A (2018) Drug repurposing screens and synergistic drug combinations for infectious diseases. Br J Pharmacol 2:181\u2013191. https:\/\/doi.org\/10.1111\/bph.13895. (PMID: 28685814)","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3242_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.2020.22106","volume":"325","author":"ME Hirschtritt","year":"2021","unstructured":"Hirschtritt ME, Olfson M, Kroenke K (2021) Balancing the risks and benefits of benzodiazepines. JAMA 325(4):347\u2013348. https:\/\/doi.org\/10.1001\/jama.2020.22106. (PMID: 33416846)","journal-title":"JAMA"},{"key":"3242_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12906-021-03359-2","volume":"21","author":"A Ibezim","year":"2021","unstructured":"Ibezim A, Onah E, Dim EM et al (2021) A computational multi-targeting approach for drug repositioning for psoriasis treatment. BMC Complement Med Ther 21:193. https:\/\/doi.org\/10.1186\/s12906-021-03359-2. (PMID: 34225727)","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"3242_CR51","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s42770-02100551-x","volume":"52","author":"D Rodrigues","year":"2021","unstructured":"Rodrigues D, Baldissera GS, Mathos D et al (2021) Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity. Braz J Microbiol 52(4):1913\u20131919. https:\/\/doi.org\/10.1007\/s42770-02100551-x. (PMID: 34191252)","journal-title":"Braz J Microbiol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03242-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T18:16:59Z","timestamp":1682619419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3242"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03242-y","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was approved by the Research Ethics Committee of the Federal University of Santa Maria, being registered under the number of the CAAE Ethical Appreciation Certificate 928.497. Registration in the National System of Genetic Heritage Management and Associated Traditional Knowledge (SisGen) is registered under number R4B27A6\u2014Federal University of Santa Maria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"160"}}